{"id":38036,"date":"2018-03-22T20:30:58","date_gmt":"2018-03-22T18:30:58","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=38036"},"modified":"2018-03-22T20:30:58","modified_gmt":"2018-03-22T18:30:58","slug":"introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/","title":{"rendered":"Introducci\u00f3 a l&#8217;epigen\u00e8tica i aplicabilitat en la medicina personalitzada"},"content":{"rendered":"<p>Els passats dies 5, 7 i 12 de mar\u00e7, el COFB, des de la seva aposta per la innovaci\u00f3, va acollir el curs<strong> &#8220;Introducci\u00f3 a l&#8217;epigen\u00e8tica i aplicabilitat en la medicina personalitzada&#8221;<\/strong>, adre\u00e7at a farmac\u00e8utics.<\/p>\n<h1><span style=\"color: #008080;\"><strong>Els objectius<\/strong><\/span><\/h1>\n<p>El curs tenia com a <strong>objectius principals:<br \/>\n<\/strong><\/p>\n<ul>\n<li><strong> Introduir el farmac\u00e8utic en el m\u00f3n de l&#8217;epigen\u00e8tica<\/strong>, a trav\u00e9s d&#8217;una visi\u00f3 general i \u00e0mplia de quins s\u00f3n els mecanismes epigen\u00e8tics de la c\u00e8l\u00b7lula i com els podem estudiar per determinar-ne la implicaci\u00f3 en malalties.<\/li>\n<li>Veure l&#8217;<strong>efecte de l&#8217;epigen\u00e8tica<\/strong> en el desenvolupament de malalties com l&#8217;Alzheimer i el c\u00e0ncer, i el paper que t\u00e9 en la medicina personalitzada.<\/li>\n<\/ul>\n<figure id=\"attachment_38048\" aria-describedby=\"caption-attachment-38048\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2018\/03\/epigen\u00e8ticaretallada.jpg\" target=\"_blank\" rel=\"noopener\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-38048 size-large\" title=\"Els alumnes del curs &quot;Introducci\u00f3 a l'epigen\u00e8tica i aplicabilitat en la medicina personalitzada&quot; seguint a formaci\u00f3. \" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2018\/03\/epigen\u00e8ticaretallada-1024x747.jpg\" alt=\"Els alumnes del curs &quot;Introducci\u00f3 a l'epigen\u00e8tica i aplicabilitat en la medicina personalitzada&quot; seguint a formaci\u00f3. \" width=\"620\" height=\"452\" \/><\/a><figcaption id=\"caption-attachment-38048\" class=\"wp-caption-text\">Els alumnes del curs &#8220;Introducci\u00f3 a l&#8217;epigen\u00e8tica i aplicabilitat en la medicina personalitzada&#8221; seguint a formaci\u00f3.<\/figcaption><\/figure>\n<div class=\"destacat-blog\">\n<h2><span style=\"color: #008080;\"><strong>El repte de l&#8217;epigen\u00e8tica<\/strong><\/span><\/h2>\n<p>L\u2019<strong>epigen\u00e8tica<\/strong> tracta de les <strong>marques qu\u00edmiques responsables de modificar l\u2019ADN<\/strong> i altres mol\u00e8cules que regulen el genoma i que s\u00f3n importants a l\u2019hora de prendre decisions gen\u00f2miques.<\/p>\n<p>El repte \u00e9s que<strong>\u00a0s\u2019incorpori a l\u2019\u00e0rea cl\u00ednica<\/strong>, \u00e9s a dir, que els marcadors epigen\u00e8tics siguin utilitzats en la presa de decisions de diagn\u00f2stic i de tractament. <strong>La investigaci\u00f3 en aquesta \u00e0rea busca tenir m\u00e9s f\u00e0rmacs<\/strong> que en l&#8217;\u00e0mbit epigen\u00e8tic siguin \u00fatils per tractar determinades patologies.<\/p>\n<\/div>\n<h1><strong><span style=\"color: #008080;\">El programa<\/span><\/strong><\/h1>\n<h2><span style=\"color: #000000;\"><strong>L&#8217;epigen\u00e8tica i els mecanismes epigen\u00e8tics<\/strong><\/span><\/h2>\n<p>En aquest bloc, es van abordar <strong>conceptes introductoris de\u00a0l&#8217;epigen\u00e8tica<\/strong>, la metilaci\u00f3 de l&#8217;ADN i la modificaci\u00f3 d&#8217;histones.<\/p>\n<h2><span style=\"color: #000000;\"><strong>Altres mecanismes epigen\u00e8tics i tecnologies per estudiar-los i aplicar-los<\/strong><\/span><\/h2>\n<p>En aquest punt, es van tractar aspectes com <strong>el m\u00f3n dels ARN no codificants<\/strong> o l&#8217;estudi de la metilaci\u00f3 i l&#8217;aplicaci\u00f3: tecnologies d&#8217;ampli espectre i dirigides.<\/p>\n<h2><span style=\"color: #000000;\"><strong>Epigen\u00e8tica i malaltia: cap a una medicina personalitzada<\/strong><\/span><\/h2>\n<p>Dins d&#8217;aquest \u00e0mbit, es van tractar aspectes com l&#8217;<strong>epigen\u00e8tica en neurobiologia<\/strong>: Alzheimer i la s\u00edndrome de Rett, epigen\u00e8tica i c\u00e0ncer i drogues epigen\u00e8tiques i assajos cl\u00ednics.<\/p>\n<figure id=\"attachment_38046\" aria-describedby=\"caption-attachment-38046\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2018\/03\/cofb.180305-35.jpg\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"wp-image-38046 size-large\" title=\"Guillermo Bagaria, vicetresorer del COFB i responsable d'Atenci\u00f3 Farmac\u00e8utica, durant la presentaci\u00f3 del curs &quot;Introducci\u00f3 a l'epigen\u00e8tica i aplicabilitat en la medicina personalitzada&quot;. \" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2018\/03\/cofb.180305-35-1024x683.jpg\" alt=\"Guillermo Bagaria, vicetresorer del COFB i responsable d'Atenci\u00f3 Farmac\u00e8utica, durant la presentaci\u00f3 del curs &quot;Introducci\u00f3 a l'epigen\u00e8tica i aplicabilitat en la medicina personalitzada&quot;. \" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-38046\" class=\"wp-caption-text\">Guillermo Bagaria, vicetresorer del COFB i responsable d&#8217;Atenci\u00f3 Farmac\u00e8utica, durant la presentaci\u00f3 del curs &#8220;Introducci\u00f3 a l&#8217;epigen\u00e8tica i aplicabilitat en la medicina personalitzada&#8221;.<\/figcaption><\/figure>\n<h1><span style=\"color: #008080;\"><strong>Valoraci\u00f3 del curs<\/strong><\/span><\/h1>\n<p>Guillermo Bagaria, <strong>vicetresorer i responsable d&#8217;Atenci\u00f3 Farmac\u00e8utica del COFB<\/strong>, va valorar positivament la formaci\u00f3 i va destacar que les tres jornades &#8220;es van fer curtes&#8221; per abordar &#8220;<strong>un m\u00f3n apassionant, complex i interconnectat<\/strong> fins als l\u00edmits del que \u00e9s comprensible, i amb <strong>un potencial molt engrescador de desenvolupament de nous medicaments<\/strong>&#8220;.<\/p>\n<p>A m\u00e9s, Bagaria va ressaltar el prestigi de l&#8217;<strong>Institut d&#8217;Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL), <\/strong>&#8220;un dels equips d&#8217;investigadors m\u00e9s potents d&#8217;Europa&#8221;, del qual formava part el quadre docent del curs.<\/p>\n<p>Finalment, va exposar tamb\u00e9 que des del COFB es considera que &#8220;<strong>la farmacogen\u00e8tica i l&#8217;epigen\u00e8tica s\u00f3n disciplines fonamentals<\/strong> en les quals el farmac\u00e8utic ha de ser un dels interlocutors entre aven\u00e7os cient\u00edfics i societat i, encara m\u00e9s, si aquests aven\u00e7os permeten albirar escenaris de tractaments individualitzats&#8221;.\u00a0 Per aix\u00f2, &#8220;<strong>se seguir\u00e0 apropant formaci\u00f3 de qualitat i aprofundint en les possibilitats que ofereix aquest nou coneixement&#8221;<\/strong>.<\/p>\n<div class=\"destacat-blog\">\n<h2><span style=\"color: #008080;\"><strong>El quadre docent va estar format per:<\/strong><\/span><\/h2>\n<p><strong>Pau Castillo:<\/strong> Grup de Biologia de la Cromatina, Programa d&#8217;Epigen\u00e8tica i Biologia del C\u00e0ncer, Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL)<br \/>\n<strong>Ver\u00f3nica D\u00e1valos,\u00a0<\/strong><strong>Raul<\/strong> <strong>Delgado,\u00a0<\/strong><strong>S\u00f2nia<\/strong> <strong>Guil i\u00a0<\/strong><strong>Anna<\/strong> <strong>Mart\u00ednez-Card\u00fas: <\/strong>Grup d&#8217;Epigen\u00e8tica del C\u00e0ncer, Programa d&#8217;Epigen\u00e8tica i Biologia del C\u00e0ncer, Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL)<br \/>\n<strong>Sebasti\u00e1n<\/strong> <strong>Moran: <\/strong>Servei de Gen\u00f2mica i Epigen\u00f2mica del PEBC, Programa d&#8217;Epigen\u00e8tica i Biologia del C\u00e0ncer, Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL)<br \/>\n<strong>C\u00e1tia<\/strong> <strong>Moutinho: <\/strong>Centre Nacional d&#8217;An\u00e0lisi Gen\u00f2mica, Programa d&#8217;Epigen\u00e8tica i Biologia del C\u00e0ncer, Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL)\n<\/div>\n<p><strong>Altres publicacions d&#8217;inter\u00e8s:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/blog.cofb.cat\/fem-cami-cap-la-farmacogenetica\/\" target=\"_blank\" rel=\"noopener\">Fem cam\u00ed cap a la farmacogen\u00e8tica (Desembre 2016)<\/a><\/li>\n<li><a href=\"https:\/\/blog.cofb.cat\/farmacogenetica-farmacia-comunitaria-la-seva-relacio-explicada-per-experts\/\" target=\"_blank\" rel=\"noopener\">Farmacogen\u00e8tica i farm\u00e0cia comunit\u00e0ria: la seva relaci\u00f3 explicada per experts (Novembre 2017)<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Els passats dies 5, 7 i 12 de mar\u00e7, el COFB, des de la seva aposta per la innovaci\u00f3, va acollir el curs &#8220;Introducci\u00f3 a l&#8217;epigen\u00e8tica i aplicabilitat en la medicina personalitzada&#8221;, adre\u00e7at a farmac\u00e8utics. Els objectius El curs tenia com a objectius principals: Introduir el farmac\u00e8utic en el m\u00f3n [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":38050,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[3022,2819,18,3015,19,2820,53,3023,70,3024,3025],"class_list":["post-38036","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-assajos-clinics-i-epigenetica","tag-cancer-i-epigenetica","tag-cofb","tag-collegi-de-farmaceutics","tag-collegi-de-farmaceutics-de-barcelona","tag-epigenetica","tag-farmaceutics","tag-farmacia-i-epigenetica","tag-formacio","tag-medicina-personalitzada","tag-tecnologia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Introducci\u00f3 a l&#039;epigen\u00e8tica i aplicabilitat en la medicina personalitzada - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"Els passats dies 5, 7 i 12 de mar\u00e7 el COFB va acollir el curs &quot;Introducci\u00f3 a l&#039;epigen\u00e8tica i aplicabilitat en la medicina personalitzada&quot;, adre\u00e7at a farmac\u00e8utics.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Introducci\u00f3 a l&#039;epigen\u00e8tica i aplicabilitat en la medicina personalitzada - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Els passats dies 5, 7 i 12 de mar\u00e7 el COFB va acollir el curs &quot;Introducci\u00f3 a l&#039;epigen\u00e8tica i aplicabilitat en la medicina personalitzada&quot;, adre\u00e7at a farmac\u00e8utics.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-22T18:30:58+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Introducci\u00f3 a l&#8217;epigen\u00e8tica i aplicabilitat en la medicina personalitzada\",\"datePublished\":\"2018-03-22T18:30:58+00:00\",\"dateModified\":\"2018-03-22T18:30:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/\"},\"wordCount\":720,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"assajos cl\u00ednics i epigen\u00e8tica\",\"cancer i epigen\u00e8tica\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"epigen\u00e8tica\",\"farmac\u00e8utics\",\"farm\u00e0cia i epigen\u00e8tica\",\"Formaci\u00f3\",\"medicina personalitzada\",\"tecnologia\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/\",\"name\":\"Introducci\u00f3 a l'epigen\u00e8tica i aplicabilitat en la medicina personalitzada - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2018-03-22T18:30:58+00:00\",\"dateModified\":\"2018-03-22T18:30:58+00:00\",\"description\":\"Els passats dies 5, 7 i 12 de mar\u00e7 el COFB va acollir el curs \\\"Introducci\u00f3 a l'epigen\u00e8tica i aplicabilitat en la medicina personalitzada\\\", adre\u00e7at a farmac\u00e8utics.\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Introducci\u00f3 a l&#8217;epigen\u00e8tica i aplicabilitat en la medicina personalitzada\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Introducci\u00f3 a l'epigen\u00e8tica i aplicabilitat en la medicina personalitzada - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"Els passats dies 5, 7 i 12 de mar\u00e7 el COFB va acollir el curs \"Introducci\u00f3 a l'epigen\u00e8tica i aplicabilitat en la medicina personalitzada\", adre\u00e7at a farmac\u00e8utics.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/","og_locale":"ca_ES","og_type":"article","og_title":"Introducci\u00f3 a l'epigen\u00e8tica i aplicabilitat en la medicina personalitzada - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Els passats dies 5, 7 i 12 de mar\u00e7 el COFB va acollir el curs \"Introducci\u00f3 a l'epigen\u00e8tica i aplicabilitat en la medicina personalitzada\", adre\u00e7at a farmac\u00e8utics.","og_url":"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2018-03-22T18:30:58+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Introducci\u00f3 a l&#8217;epigen\u00e8tica i aplicabilitat en la medicina personalitzada","datePublished":"2018-03-22T18:30:58+00:00","dateModified":"2018-03-22T18:30:58+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/"},"wordCount":720,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#primaryimage"},"thumbnailUrl":"","keywords":["assajos cl\u00ednics i epigen\u00e8tica","cancer i epigen\u00e8tica","COFB","Col\u00b7legi de Farmac\u00e8utics","Col\u00b7legi de Farmac\u00e8utics de Barcelona","epigen\u00e8tica","farmac\u00e8utics","farm\u00e0cia i epigen\u00e8tica","Formaci\u00f3","medicina personalitzada","tecnologia"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/","url":"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/","name":"Introducci\u00f3 a l'epigen\u00e8tica i aplicabilitat en la medicina personalitzada - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#primaryimage"},"thumbnailUrl":"","datePublished":"2018-03-22T18:30:58+00:00","dateModified":"2018-03-22T18:30:58+00:00","description":"Els passats dies 5, 7 i 12 de mar\u00e7 el COFB va acollir el curs \"Introducci\u00f3 a l'epigen\u00e8tica i aplicabilitat en la medicina personalitzada\", adre\u00e7at a farmac\u00e8utics.","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2018\/03\/22\/introduccio-a-lepigenetica-i-aplicabilitat-en-la-medicina-personalitzada\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Introducci\u00f3 a l&#8217;epigen\u00e8tica i aplicabilitat en la medicina personalitzada"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Els passats dies 5, 7 i 12 de mar\u00e7, el COFB, des de la seva aposta per la innovaci\u00f3, va acollir el curs &#8220;Introducci\u00f3 a l&#8217;epigen\u00e8tica i aplicabilitat en la medicina personalitzada&#8221;, adre\u00e7at a farmac\u00e8utics. Els objectius El curs tenia com a objectius principals: Introduir el farmac\u00e8utic en el m\u00f3n [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/38036","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=38036"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/38036\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=38036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=38036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=38036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}